fluorescent labeling, cancer

Drug-delivering nanoparticles designed to glow when their target cells die can report on the effectiveness of cancer therapies within just a few hours of treatment, a mouse study shows.

Researchers have developed a technique to visualize the origin of melanoma in zebrafish, throwing light on a genetic switch for cancer.

A new camera system supports the visualization of gliomas stained with Tumor Paint, a chlorotoxin-based imaging agent that’s currently in clinical trials.

Scientists create biocompatible, self-luminescing nanoparticles for in vivo imaging.